Assessment of the Economic Impact of Belimumab for the Treatment of Systemic Lupus Erythematosus in the Italian Setting: A Cost-Effectiveness Analysis

OBJECTIVE: The purpose of this analysis is to evaluate the cost-effectiveness of belimumab, a new biological treatment specifically developed for the treatment of Systemic Lupus Erythematosus (SLE), in the Italian setting. SLE is a chronic non-organ specific autoimmune disease characterized by a dis...

Descripción completa

Detalles Bibliográficos
Autores principales: Pierotti, Francesca, Palla, Ilaria, Treur, Maarten, Pippo, Lara, Turchetti, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4619253/
https://www.ncbi.nlm.nih.gov/pubmed/26488751
http://dx.doi.org/10.1371/journal.pone.0140843

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4619253/
https://www.ncbi.nlm.nih.gov/pubmed/26488751
http://dx.doi.org/10.1371/journal.pone.0140843

Ejemplares similares